Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini-review articles and guest-edited issues on drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government, and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and, most importantly, drug metabolism.
More specifically, the journal covers in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling, and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; and bioactivation, reactive metabolites, and developments for the identification of drug metabolites. It also includes preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.
Current Drug Metabolism is an international, peer-reviewed journal on all aspects of drug metabolism, published monthly (print & online) by Bentham Science Publishers.
Current Drug Metabolism (CDM)
is :
International, Peer-Reviewed, Open Access, Refereed,
pharmaceutics, pharmacokinetics, toxicology
,
Online
or
Print,
Monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 1389-2002, E-ISSN - 1875-5453, Established in - 2000, Impact Factor - 1.8
Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Services for Journal Owners:
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
Indexing and Contact Detail:
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Limitations of Responsibility:
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Resolution of Disputes:
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.
True scholar network
